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Wilkins score for severe mitral stenosis: what is beyond the procedu-
ral considerations?
Majed Hassine, Ibtihel Mechri, Ghassen Chniti, Marouen Mahjoub, Mejdi
Ben Massoud, Nidhal Bouchahda, Zohra Dridi, Fethi Betbout, Habib
Gamra
Hôpital Fattouma Bourguiba, Cardiologie A, Monastir, Tunisie
Background: Percutaneous transvenous mitral balloon valvotomy
(PTMV) optimal results are usually achieved when echocardiographic Wilkins
score (WS) is ≤8. WS from 9 to 11 represent a gray zone in which only some
patients have good results. 
Aim: The aim of this study was to determine the early and long term
results of this procedure in patients with WS 8 or less and at the gray WS
zone.
Methods: Retrospective review of clinical records of patients with
rheumatic MS submitted to PTMV from January 1990 to December 2010.
Follow-up was obtained by clinical records when available. Procedure was
considered unsuccessful when post-procedure MV area (MVA) was
<1.5cm2.
Results: We analyzed data for 378 patients with a WS ≤11, 80.5% were
women. Mean age at the time of repair was 33 years [10 to 76 years] and the
mean follow up time was 74 months. Before the procedure, 33.9% had a WS
in the gray zone. They were older (36 years vs. 31 years, p<0.001) with a fre-
quent history of mitral valvuloplasty (34.4% vs. 12%, p <0.001). Males pre-
sented more in the gray zone (25.8% vs 16.8%, p = 0.038) while pregnant
women had a WS ≤8 (20.4% vs. 11.7%, p= 0.035). Patients in the gray zone
presented more frequently with atrial fibrillation (39.1% vs. 21.2%, p< 0.001).
There was no differences regarding the functional status or the baseline
echocardiographic MVA measurement by planimetry (1.07cm2 vs 1.05cm2,
p=0.26).
PTMV was safe in the two groups with same rates of success but a lower
mitral surface gain in the gray zone group (0.88cm2 vs. 1.05cm2, p<0.001).
During follow up, patients in the gray zone had significantly lower event
free survival (freedom from death, systemic embolism and restenosis) (58.6%
vs. 69.2%, p<0.001) and had a higher mortality (3.9% vs 0.8%, 0.023), higher
rates of restenosis (33.6% vs. 17.8%, p<0.001) and required more frequently
a mitral valve replacement (16.4% vs. 8.9%, p= 0.005)
Conclusion: PTMV was a safe procedure in both WS groups. Optimal
results patients with a WS≤8 zone. Patients with a WS 9-11 experienced
worse outcomes during follow up. 
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Percutaneous balloon mitral commissurotomy in children and young
adults with rheumatic mitral stenosis
Leila Abid, Selma Charfeddine, Dorra Abid, Ahmed Siala, Ahmed Tounsi,
Samir Kammoun
CHU Hédi Chaker, Cardiologie, Sfax, Tunisie 
Objective: To determine the efficacy and the safety of percutaneous bal-
loonmitral commissurotomy (PBMC) in young patients (aged under 18 years
– olds) with rheumatic mitral stenosis and to compare these results with those
of adult patients. 
Patients and Methods: Percutaneous transvenous mitral commissurotomy
(PTMC) using the Inoue technique was performed in 480 patients with rheu-
matic mitral stenosisbetween 1998 and 2013. 41 were aged under 18 years –
old (group 1). The other 439 patients (group 2) had a mean age of 34±11.9
years. All patients were assessed clinically. An echocardiography was per-
formed before and after the procedure. 
Results: Mean age in group 1 was 15±2.95 years (range 8 to 18) with a
women predominance (73.2% vs. 26.8%.). In group 1, there was a significant
increase of the mean mitral valve area index (MVAI) (0.84±0.24 vs
1.78±0.39cm2, p <0.001), a significant reduction of the mean transmitral pres-
sure gradient (21.78±6.62to8.75±5.87mm Hg, p <0.001) and of the mean left
atrial pressure (28.46±7.59to12.87±5.57 mmHg, p < 0,001) from pre- to post-
PBMC, respectively. Mild mitral regurgitation developed in 12 and moderate
mitral regurgitation developed in 3 patients.The mean follow-up was 92±40
months. Improvement in symptomatic status by at least one NYHA class was
seen in the majority of patients.A good result during the follow up was
observed in 46.3% of controlled patients and restenosis in 53.7% of cases with
an average of 46±34 months. The immediate hemodynamic results in children
were compared to 439 adult patients who underwent PBMC in the same
period. The outcome was similar in both groups. Children were found to have
significantly higher rate of mitral restenosis compared to adults (53.7% vs.
31.9%). 
Conclusion: Despite a high rate of restenosis, PBMC is very effective and
safe in children, and consider that it should be the procedure of choice for
young patients with symptomatic rheumatic mitral stenosis. 
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Factors predicting mitral restenosis after successful percutaneous
mitral commissurotomy
Leila Bezdah, Emna Allouche, Hbib Ben Ahmed, S.Mohamed, Slim Sid-
hom, W.Ouchtati, Hédi Baccar
Hôpital Charles Nicolle, Cardiologie, Tunis, Tunisie
Introduction: Percutaneous mitral commissurotomy (PMC) is the alterna-
tive treatment of choice for mitral stenosis (MS). Its immediate and medium
term results are comparable to those of surgical commissurotomy, however in
the long term there is a risk of restenosis. The purpose of this study was to
determine the factors predicting restenosis after PMC.
Methods: 322 patients (66% women), average age: 35±13 years (9-
75 years) having a tight MS and treated by PMC with Inoué balloon. The ana-
tomic aspect of the mitral apparatus before PMC has been studied according
to the criteria of the Wilkins score with a concomitant study of the state of
mitral commissures. The primary success of PMC was defined as follows:
mitral area (MA) post-PMC >1,5cm2 and gain in MA >25% and mitral regur-
gitation (MR) ≤ grade 2. Mitral restenosis is defined as a MA <1,5cm2 and/or
loss > 50% of initial gain in MA.
Results: The rate of primary success of PMC was 86% and mean MA
post PMC was 1,82±0,33 cm² compared to MA pre-PMC of 1±0,18cm²
(p<0.0001). Opening of two commissures has been observed in 74% of
patients. After an average period of 62±32 months, only 12% of patients had
a dyspnea stage III-IV of NYHA, MA was 1,64±0.3cm² (p<0.001) and
mitral restenosis happened in 47 patients (20%) after a period of 60,48±27
months (22-124 months). The independent predictors of mitral restenosis
after a successful PMC were: previous surgical commisurotomy, Wilkins
score >8, MA after PMC <1,8 cm² and absence of bicommissural opening
post PMC.
Conclusion: A favorable anatomy of mitral apparatus and the optimisation
of immediate result of PMC are the guaranty for the maintain of good result
in the long term. 
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Evolution of mitral organic valve disease in Vietnam during last two
decades
Inès Cazaubiel (1), Bernard Iung (2)
(1) CHU Hôpital Saint Antoine-APHP, Cardiologie, Paris, France –
(2) CHU Bichat-Claude Bernard-APHP, Cardiologie, Paris, France
Introduction: Currently, degenerative etiologies of valvular diseases pre-
dominate in developed countries, but there are few data in developing coun-
tries like Vietnam.
Methods: This Vietnamese retrospective study included 2734 patients who
had mitral valve surgery in the Heart Institute, in Ho Chi Minh City, Vietnam.
They were divided into two periods: 1636 cases in 1995-2000 and 1098 cases
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in 2005-2010. The etiology and type of valvular heart disease have been clas-
sified on the basis of surgicalreports.
Results: The distribution of etiologies differed significantly different
between the two periods (p<0.0001). We noted a decrease in rheumatic
valvular disease with 1,558 cases (95%) in the first period and 894 cases
(81%) in the second period. Consistantly, we observed an increase in
degenerative etiology from 1.6% to 16%, and particularly fibroelastic
degeneration: 20 (1.6%) and 146 (13.3%) cases. The mechanism of val-
vular disease (mitral regurgitation versus mixed mitral valve disease and
mitral stenosis) differed significantly (p<0.0001) for both periods. With
regard to mitral regurgitation cases only, degenerative etiologies increased
from 11.4% to 38.5% of cases between the two periods (p<0.0001).
Patients had a mean age of 36.3 years with a female predominance (two
thirds of patients), especially in rheumatic etiologies. Age (p<0.0001) and
the proportion of urban residents (p=0.04) was increased in degenerative
causes.
Conclusion: The study shows the emergence of degenerative valvular
disease in Vietnam and a decrease in rheumatic valvular heart disease, which
nevertheless remains the most common etiology. 
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Mutations in the gene encoding FilGAP as a cause for mitral valve
prolapse
Antoine Rimbert, Damien Duval, Florence Kyndt, Simon Lecointe, Vin-
cent Probst, Thierry Le Tourneau, Jean Mérot, Jean-Jacques Schott
U1087, Nantes, France
The mitral valve prolapse (MVP) is a common cardiac disorder which
affects 2-4% of the population and remains one of the most frequent
indications for valvular surgery. The familial nature of MVP has been
proposed for many years and so far, FLNA remains the only identified
gene. 
Recently, it has been shown that FLNA mutations deregulate the RhoA/
Rac1 GTPases balance and provided evidences for a role of the Rac1 specific
GTPase activating protein, FilGAP, in this network. FilGAP is a recognized
FlnA-binding RhoGTPase-activating protein.
Giving the tight interactions of FlnA and FilGAP, we first tested, using a
candidate gene approach, the hypothesis that FilGAP, encoded by ARHGAP24,
could be involved in MVP.
We have sequenced ARHGAP24 in 95 MVP operated patients and identi-
fied 3 rare missense mutations in highly conserve residues (FilGAP p.R95Q;
p.P417H and p.T481M). One mutation was novel and the 2 others present a
minor allele frequency lower than 0.1% in EVS. Moreover, p.T481M co-seg-
regates with the pathology in a family with 3 affected patients.
We then investigated the impact of these mutations in HEK293 cells. The
role of FilGAP is to decrease Rac1 activity and thus to regulate cell processes
involved in actin cytoskeleton properties as adhesion, protrusion and intracel-
lular dynamics.
From pull-down assays, we have shown that FilGAP mutations alter Rac1
GTPase activity and significantly decrease the FilGAP interaction with the
active form of Rac1 (p<0.01). We have also shown, using the XCELLigence
system, that cell adhesion and spreading was significantly increased with
mutated FilGAP (p<0.01). Our results indicate that ARHGAP24 variants are
loss-function mutations.
Moreover, we demonstrate that FilGAP mutations alter the downstream
signaling pathway by two different mechanisms. FilGAP p.P417H and
p.T481M decrease the interaction with FlnA while p.R95Q impacts the plasma
membrane anchorage. 
This work reinforces the involvement of GTPases pathway in MVP patho-
genesis.
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Value of the mean mitral gradient predictive of dyspnea in mitral ste-
nosis in stress echo Doppler cardiac at peak effort
Fadila Daimellah (1), Saléha Lehachi (1), Saida Khelil (1), Zakia Bennoui (1),
Imene Hachemaoui (1), Djohar Hannoun (2), Youcef Laid (2), Mohand Said
Issad (1)
(1) CHU Béni Messous, Cardiologie, Alger, Algérie – (2) Institut National
de Santé Publique, Alger, Algérie
Background: In stress echo Doppler cardiac of mitral stenosis (MS), the
cut point of the mean mitral gradient (MMG) at the peak of the effort pro-
posed by the American Recommendations for mitral dilation is 15mmHg.
However, this value is questioned in the literature
Objective: In stress echo Doppler, determine the peak effort cutoff value
of the MMG prediction of the occurrence of dyspnea justifying percutaneous
mitral dilation in patients with MS
Methodology: Prospective descriptive study conducted in the Cardiology
Department Hospital Beni Messous (Algiers) between March 2008 and
December 2010. Have been included patients with mitral area ≤2 cm², func-
tional class I to III NYHA and systolic pulmonary artery pressure ≤60mm Hg
at rest. Dyspnea was sought to stress test on a treadmill (30W/3min). Dyspneic
patients are those who have stopped the examination for a load ≤90W due to
the occurrence of severe dyspnea. The stress echo Doppler was performed on
table echocardiography (30W/3min). The MMG was measured at baseline and
at the end of each level to the peak of the effort 
Results: Three hundred patients were included (mean age 42.3±1.3 years,
81.3% female). At the end of the stress test, 182 had dyspnea (60.6%). Areas
under the curve of the MMG at peak stress is equal to 0.80, 95% confidence
interval= 0.75-0.85 (p<10-3). In predicting dyspnea justifying percutaneous
mitral dilation, the optimal cutoff value of the MMG corresponds to 33.5
mmHg: sensitivity=0.55, specificity=0.96, positive likelihood=13.21, positive
predictive value (PPV) =95%, positive predictive error (PPE) =5%, Informa-
tive Expected Capacity (IEC) =109. However, the diagnostic quality of the
MMG at maximum effort with the cut point of 15 mmHg proposed by the
American Recommendations is low: sensitivity=0.98, specificity=0.008, posi-
tive likelihood=0.98, PPV=60.0%, PPE=40.0%, IEC= 0.25.
Conclusion: In this study, the optimal cutoff value of the MMG predictive
peak effort dyspnea justifying the percutaneous mitral dilation is 33.5 mmHg,
above the cut point proposed by American Guidelines. 
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Assessment of paravalvular aortic regurgitation after transcatheter
aortic valve implantation using cardiac magnetic resonance imaging:
a comparative study with echocardiography and angiography
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Bauer (1), Matthieu Godin (1), Christophe Tron (1), Carlos Rodriguez
Camacho (1), Alain Cribier (1), Jean-Nicolas Dacher (2), Hélène Eltcha-
ninoff (1)
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Assessment of paravalvular aortic regurgitation (AR) after transcatheter
aortic valve implantation (TAVI) using Edwards SAPIEN XT valve remains
challenging using transthoracic echocardiography (TTE) or angiography. Car-
diac magnetic resonance imaging (c-MRI) has a low intraobserver and
interobserver variability in the assessment of regurgitant volumes and might
be more reliable to assess AR post-TAVI. We therefore aimed to evaluate the
value of c-MRI to assess paravalvular AR after TAVI. Between February
2012 and March 2013, 132 consecutive patients underwent successful TAVI
using exclusively Edwards SAPIEN XT prosthesis. AR was evaluated by c-
MRI, TTE and angiography in 45 patients (27 women, mean age 84.1±7.1
years). Angiography was performed immediately after TAVI whereas TTE
and c-MRI were performed one month after implantation. At baseline c-MRI,
the mean aortic regurgitant fraction (ARF) was 21.3±12.5%. A significant AR
(> grade II) was present in 24 (56%) patients using c-MRI (30< ARF>50 Y%)
whereas it was only observed in 18 (40%) and 12 (27%) patients using TTE
and angiography, respectively. Interestingly, there was a poor correlation
between c-MRI and TTE (r=0.16, p=0.28) and between c-MRI and angio-
graphy (r=0.30, p=0.06). In contrast, there was a good correlation between
TTE and angiography (r=0.6, p<0.001). TTE underestimated AR by one
degree in 9 patients, and by two degrees in 6 patients as compared to c-MRI.
The results of our study suggest that TTE and angiography may underestimate
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